Sanofi — Director's Dealing 2012

Aug 10, 2012

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: KALOBIOS PHARMACEUTICALS INC (KALOP)
CIK: 0001293310
Period of Report: 2012-08-11

Reporting Person: Sanofi (10% Owner)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Preferred Shares	$		Ordinary Shares (1538461)		Indirect

Footnotes

F1: Exercisable at any time.

F2: Not applicable.

F3: One-for-one.

F4: by wholy-owned subsidiary Genzyme Corp.